| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444840 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
200Â mg OSI-930 BIDÂ +Â 150Â mg erlotinib QD were the recommended doses for further evaluation of this combination.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
I.R. Macpherson, S. Poondru, G.R. Simon, R. Gedrich, K. Brock, C.A. Hopkins, K. Stewart, A. Stephens, T.R.J. Evans,